Tyme Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TYME and buy or sell other stocks, ETFs, and their options commission-free!About TYME
Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis.
CEORichard Anthony Cunningham
CEORichard Anthony Cunningham
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
TYME Key Statistics
Market cap53.50M
Market cap53.50M
Price-Earnings ratio-2.21
Price-Earnings ratio-2.21
Dividend yield—
Dividend yield—
Average volume1.54M
Average volume1.54M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.14
52 Week high$1.14
52 Week low$0.2187
52 Week low$0.2187
People also own
Based on the portfolios of people who own TYME. This list is generated using Robinhood data, and it’s not a recommendation.